Brown Brothers Harriman & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84 Sell
5
-395
-99% -$6.64K ﹤0.01% 1536
2025
Q1
$6.15K Buy
400
+376
+1,567% +$5.78K ﹤0.01% 1125
2024
Q4
$529 Hold
24
﹤0.01% 1402
2024
Q3
$432 Hold
24
﹤0.01% 1380
2024
Q2
$390 Buy
+24
New +$390 ﹤0.01% 1118
2022
Q4
Sell
-38
Closed 1492
2022
Q3
$0 Buy
+38
New ﹤0.01% 1586
2020
Q3
Sell
-90
Closed -$1K 1033
2020
Q2
$1K Buy
+90
New +$1K ﹤0.01% 950
2019
Q1
Sell
-441
Closed -$7K 1106
2018
Q4
$7K Buy
+441
New +$7K ﹤0.01% 745
2018
Q3
Sell
-1,499
Closed -$36K 884
2018
Q2
$36K Hold
1,499
﹤0.01% 533
2018
Q1
$26K Buy
+1,499
New +$26K ﹤0.01% 553
2017
Q4
Sell
-600
Closed -$11K 1207
2017
Q3
$11K Sell
600
-525
-47% -$9.63K ﹤0.01% 656
2017
Q2
$37K Hold
1,125
﹤0.01% 514
2017
Q1
$36K Sell
1,125
-121
-10% -$3.87K ﹤0.01% 525
2016
Q4
$45K Sell
1,246
-234
-16% -$8.45K ﹤0.01% 503
2016
Q3
$68K Buy
1,480
+600
+68% +$27.6K ﹤0.01% 413
2016
Q2
$44K Buy
880
+41
+5% +$2.05K ﹤0.01% 468
2016
Q1
$45K Sell
839
-420
-33% -$22.5K ﹤0.01% 450
2015
Q4
$83K Sell
1,259
-3,148
-71% -$208K ﹤0.01% 407
2015
Q3
$249K Buy
4,407
+873
+25% +$49.3K ﹤0.01% 302
2015
Q2
$209K Sell
3,534
-3,830
-52% -$227K ﹤0.01% 329
2015
Q1
$459K Sell
7,364
-115
-2% -$7.17K ﹤0.01% 268
2014
Q4
$430K Sell
7,479
-238,770
-97% -$13.7M ﹤0.01% 278
2014
Q3
$13.2M Sell
246,249
-366
-0.1% -$19.7K 0.05% 67
2014
Q2
$12.9M Sell
246,615
-716
-0.3% -$37.5K 0.05% 69
2014
Q1
$13.1M Sell
247,331
-2,619
-1% -$138K 0.06% 66
2013
Q4
$10M Sell
249,950
-282,025
-53% -$11.3M 0.05% 72
2013
Q3
$20.1M Buy
531,975
+3,800
+0.7% +$144K 0.1% 55
2013
Q2
$20.7M Buy
+528,175
New +$20.7M 0.1% 57